Sacroileitis and peripheral arthropathy associated with ulcerative colitis: Effect of infliximab on both articular and intestinal symptoms

Digestive and Liver Disease

Volumn 36, Issue 6, 2004, Pages 423-425

  Lupascu, A ^a   Armuzzi, A ^a   De Pascalis, B ^a   Carloni, E ^a   Lauritano, E C ^a   Gasbarrini, A ^a,b   Pola, P ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Major Hospital   (Italy)

Author keywords

Infliximab; Peripheral arthropathy; Sacroileitis; Ulcerative colitis

Indexed keywords

INFLIXIMAB; MESALAZINE; METHYLPREDNISOLONE; ROFECOXIB; GASTROINTESTINAL AGENT; MONOCLONAL ANTIBODY;

ABDOMINAL PAIN; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTHROPATHY; ARTICLE; BACKACHE; CASE REPORT; COLON POLYP; DIARRHEA; DISEASE ASSOCIATION; EDEMA; FEMALE; FEVER; HOSPITAL ADMISSION; HUMAN; MORNING STIFFNESS; RECTUM HEMORRHAGE; REMISSION; SACROILIITIS; ULCERATIVE COLITIS; SACROILIAC JOINT; SYNOVITIS;

ADULT; ANTIBODIES, MONOCLONAL; COLITIS, ULCERATIVE; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; SACROILIAC JOINT; SYNOVITIS;

EID: 85047690625     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(04)00089-1     Document Type: Article

References (18)

1. Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W, et al. Treatment of active ankylosing spondylitis with infliximab: A randomised controlled multicentre trial. Lancet 2002;359:1187-93.
2. Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000;343:1594-602.
3. Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, et al. A short term study of chimeric monoclonal antibody cA2 to tumor necrosis for Crohn's disease. N Engl J Med 1997;337:1029-35.
4. Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999;340:1398-405.
5. Su C, Salzberg BA, Lewis JD, Deren JJ, Kornbluth A, Katzka DA, et al. Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis. Am J Gastroenterol 2002;97:2577-84.
6. Chey WY, Hussain A, Ryan C, Potter GD, Shah A. Infliximab for refractory ulcerative colitis. Am J Gastroenterol 2001;96:2373-81.
7. Probert CS, Hearing SD, Schreiber S, Kuhbacher T, Ghosh S, Arnott ID, et al. Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: A randomised controlled trial. Gut 2003;52(7):998-1002.
8. Smale S, Natt RS, Orchard TR, Russell AS, Bjarnason I. Inflammatory bowel disease and spondyloarthropathy. Arthritis Rheum 2001;44:2728-36.
9. Brandt J, Haibel H, Reddig J, Sieper J, Braun J. Successful short term treatment of severe undifferentiated spondyloarthropathy with the anti-tumor necrosis factor-alpha monoclonal antibody infliximab. J Rheumatol 2002;29:118-22.
10. Maksymowych WP, Jhangri GS, Lambert RG, Mallon C, Buenviaje H, Pedrycz E, et al. Infliximab in ankylosing spondylitis: A prospective observational inception cohort analysis of efficacy and safety. J Rheumatol 2002;29:959-65.
11. Breban M, Vignon E, Claudepierre P, Devauchelle V, Wendling D, Lespessailles E, et al. Efficacy of infliximab in refractory ankylosing spondylitis: Results of a six-month open-label study. Rheumatology 2002;41:1280-5.
12. Marzo-Ortega H, McGonagle D, O'Connor P, Emery P. Efficacy of etanercept for the treatment of Crohn's disease related spondyloarthropathy but not colitis. Ann Rheum Dis 2003;62:74-6.
13. Reinisch W, Miehsler W, Dejaco C, Harrer M, Waldhoer T, Lichtenberger C, et al. An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia. Aliment Pharmacol Ther 2003;17:1371-80.
14. Mahadevan U, Loftus Jr EV, Tremaine WJ, Sandborn WJ. Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease. Am J Gastroenterol 2002;97:910-4.
15. Biancone L, Tosti C, De Nigris F, Fantini M, Pallone F. Selective cyclooxygenase-2 inhibitors and relapse of inflammatory bowel disease. Gastroenterology 2003;125:637-8.
16. Fries W, Giofre MR, Catanoso M, Lo Gullo R. Treatment of acute uveitis associated with Crohn's disease and sacroileitis with infliximab. Am J Gastroenterol 2002;97:499-500.
17. Van den Bosch F, Kruithof E, De Vos M, De Keyser F, Mielants H. Crohn's disease associated with spondyloarthropathy: Effect of TNF-α blockade with infliximab on articular symptoms. Lancet 2000;25:1821-2.
18. Herfarth H, Obermeier F, Andus T, Rogler G, Nikolaus S, Kuehbacher T, et al. Improvement of arthritis and arthralgia after treatment with infliximab (remicade) in a German prospective, open-label, multicenter trial in refractory Crohn disease. Am J Gastroenterol 2002;97:2688-90.